296 related articles for article (PubMed ID: 36810081)
1. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities.
Peng B; Hu Q; He R; Hou H; Lian D; Chen Y; Li H; Song L; Gao Y; Chen T; Zhang G; Li J
BMC Complement Med Ther; 2023 Feb; 23(1):62. PubMed ID: 36810081
[TBL] [Abstract][Full Text] [Related]
2. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
3. DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models.
Zhang Z; Wu Y; Wu B; Qi Q; Li H; Lu H; Fan C; Feng C; Zuo J; Niu L; Tang W
Arthritis Res Ther; 2019 Dec; 21(1):290. PubMed ID: 31842999
[TBL] [Abstract][Full Text] [Related]
4. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
[TBL] [Abstract][Full Text] [Related]
5. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
Jiang Y; Hu F; Li M; Li Q
Clin Exp Pharmacol Physiol; 2024 Feb; 51(2):e13834. PubMed ID: 38037494
[TBL] [Abstract][Full Text] [Related]
7. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
Kasamatsu H; Chino T; Hasegawa T; Utsunomiya N; Utsunomiya A; Yamada M; Oyama N; Hasegawa M
Arthritis Res Ther; 2023 Aug; 25(1):156. PubMed ID: 37626391
[TBL] [Abstract][Full Text] [Related]
8. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
9. Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization.
Deng L; Ouyang B; Shi H; Yang F; Li S; Xie C; Du W; Hu L; Wei Y; Dong J
J Ethnopharmacol; 2023 Dec; 317():116810. PubMed ID: 37331450
[TBL] [Abstract][Full Text] [Related]
10. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
11. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
Zhu L; Song Y; Li M
J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
[TBL] [Abstract][Full Text] [Related]
13. Baicalein attenuates bleomycin-induced lung fibroblast senescence and lung fibrosis through restoration of Sirt3 expression.
Ji-Hong Y; Yu M; Ling-Hong Y; Jing-Jing G; Ling-Li X; Lv W; Yong-Mei J
Pharm Biol; 2023 Dec; 61(1):288-297. PubMed ID: 36815239
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX
Luong VH; Utsunomiya A; Chino T; Doanh LH; Matsushita T; Obara T; Kuboi Y; Ishii N; Machinaga A; Ogasawara H; Ikeda W; Kawano T; Imai T; Oyama N; Hasegawa M
Arthritis Rheumatol; 2019 Nov; 71(11):1923-1934. PubMed ID: 31173491
[TBL] [Abstract][Full Text] [Related]
15. Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models.
Shen Z; Su T; Chen J; Xie Z; Li J
Ann Transl Med; 2021 May; 9(9):801. PubMed ID: 34268414
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
Dufour AM; Alvarez M; Russo B; Chizzolini C
Front Immunol; 2018; 9():1865. PubMed ID: 30150989
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.
Wu T; Chu H; Tu W; Song M; Chen D; Yuan J; Yu L; Ma Y; Liu Q; Jin L; Zhou X; Zou H; Wu W; Wang J
BMC Complement Altern Med; 2014 Jul; 14():224. PubMed ID: 24998426
[TBL] [Abstract][Full Text] [Related]
18. Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.
Kajii M; Suzuki C; Kashihara J; Kobayashi F; Kubo Y; Miyamoto H; Yuuki T; Yamamoto T; Nakae T
Clin Exp Immunol; 2011 Feb; 163(2):235-41. PubMed ID: 21091669
[TBL] [Abstract][Full Text] [Related]
19. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
[TBL] [Abstract][Full Text] [Related]
20. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
